BR0111440A - Compostos eficazes como agonistas do (beta)2-adrenorreceptor bem como inibidores de pde4 - Google Patents
Compostos eficazes como agonistas do (beta)2-adrenorreceptor bem como inibidores de pde4Info
- Publication number
- BR0111440A BR0111440A BR0111440-9A BR0111440A BR0111440A BR 0111440 A BR0111440 A BR 0111440A BR 0111440 A BR0111440 A BR 0111440A BR 0111440 A BR0111440 A BR 0111440A
- Authority
- BR
- Brazil
- Prior art keywords
- well
- beta
- pde4 inhibitors
- compounds effective
- adrenoreceptor agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSTOS EFICAZES COMO AGONISTAS DO <225>2-ADRENORRECEPTOR BEM COMO INIBIDORES DE PDE4". A invenção refere-se a compostos da fórmula I nos quais Ar~ 1~, A, R6, R7, R8 e Ar~ 2~ têm os significados conforme fornecidos na descrição que são novos terapêuticos brónquicos eficazes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00111795 | 2000-06-05 | ||
PCT/EP2001/006230 WO2001094319A1 (en) | 2000-06-05 | 2001-06-01 | Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0111440A true BR0111440A (pt) | 2003-06-03 |
Family
ID=8168897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0111440-9A BR0111440A (pt) | 2000-06-05 | 2001-06-01 | Compostos eficazes como agonistas do (beta)2-adrenorreceptor bem como inibidores de pde4 |
Country Status (20)
Country | Link |
---|---|
US (1) | US6933296B2 (pt) |
EP (1) | EP1296956A1 (pt) |
JP (1) | JP2003535850A (pt) |
KR (1) | KR20030031907A (pt) |
CN (1) | CN1471515A (pt) |
AU (2) | AU2001262332B2 (pt) |
BR (1) | BR0111440A (pt) |
CA (1) | CA2411351A1 (pt) |
CZ (1) | CZ20023997A3 (pt) |
EA (1) | EA005824B1 (pt) |
HK (1) | HK1052346A1 (pt) |
HU (1) | HUP0301240A3 (pt) |
IL (1) | IL152846A0 (pt) |
MX (1) | MXPA02012042A (pt) |
NO (1) | NO20025811L (pt) |
NZ (1) | NZ522882A (pt) |
PL (1) | PL358057A1 (pt) |
SK (1) | SK17052002A3 (pt) |
WO (1) | WO2001094319A1 (pt) |
ZA (1) | ZA200209598B (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030074817A (ko) | 2001-02-15 | 2003-09-19 | 알타나 파마 아게 | Pde4 억제제로서의 프탈라지논-피페리디노-유도체 |
NZ529221A (en) | 2001-04-25 | 2005-04-29 | Altana Pharma Ag | Phthalazinones with PDE-inhibiting properties for treatment of airway disorders and other inflammatory conditions |
KR20030089723A (ko) | 2001-04-25 | 2003-11-22 | 알타나 파마 아게 | 피페라지노-유도체 및 이것의 pde4 억제제로서의 용도 |
ES2195785B1 (es) * | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
EP1537100B1 (en) * | 2002-08-10 | 2007-04-25 | ALTANA Pharma AG | Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
PL373146A1 (en) * | 2002-08-10 | 2005-08-22 | Altana Pharma Ag | Pyridazinone-derivatives as pde4 inhibitors |
EP1542987A1 (en) * | 2002-08-10 | 2005-06-22 | ALTANA Pharma AG | Piperidine-n-oxide-derivatives |
US20070117978A1 (en) * | 2002-12-23 | 2007-05-24 | Artesian Therapecutics, Inc | Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
JP4778449B2 (ja) | 2004-02-04 | 2011-09-21 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pde4インヒビターとしての2−(ピペリジン−4−イル)−4,5−ジヒドロ−2h−ピリダジン−3−オン誘導体 |
EP1716123A1 (en) * | 2004-02-04 | 2006-11-02 | Altana Pharma AG | Pyridazinone derivatives and their use as pde4 inhibitors |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
EP2218442A1 (en) | 2005-11-09 | 2010-08-18 | CombinatoRx, Inc. | Methods, compositions, and kits for the treatment of ophthalmic disorders |
GB0602778D0 (en) | 2006-02-10 | 2006-03-22 | Glaxo Group Ltd | Novel compound |
GB0805535D0 (en) | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
US8969348B2 (en) | 2008-08-13 | 2015-03-03 | Boehringer Ingelheim International Gmbh | Chymase inhibitors |
NZ603136A (en) * | 2010-05-10 | 2014-11-28 | Gilead Sciences Inc | Bifunctional quinoline derivatives |
AR081377A1 (es) | 2010-05-10 | 2012-08-29 | Gilead Sciences Inc | Compuestos de pirazolopiridina bifuncionales |
BR112013031791A2 (pt) * | 2011-06-17 | 2017-01-31 | Takeda Gmbh | derivados de ftalazinona-pirrolopirimidinacarboxamida |
WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
GB2513297A (en) | 2013-03-08 | 2014-10-29 | Univ Leicester | Methods |
AU2019374812A1 (en) | 2018-11-06 | 2021-06-10 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
EP3877376B1 (en) | 2018-11-06 | 2023-08-23 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
WO2021231572A1 (en) * | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3063196D1 (en) | 1979-12-05 | 1983-06-16 | Morishita Pharma | Derivatives of 2-substituted-6-phenyl-3(2h)pyridazinone, their production and pharmaceutical compositions containing them |
JPS58146571A (ja) | 1982-02-25 | 1983-09-01 | Morishita Seiyaku Kk | ウレア誘導体およびその製造法 |
PL164079B1 (pl) * | 1990-06-15 | 1994-06-30 | Akad Medyczna | posób wytwarzania nowych 2-amlnoalkilopochodnych 5-aminometyleno-6-/p-chlorofenylo /-4,5-dihydro-2H- plrydazyn -3-onu |
JP3100984B2 (ja) | 1992-12-02 | 2000-10-23 | ファイザー・インク. | 選択的pde▲下i▼▲下v▼阻害物質としてのカテコールジエーテル類 |
DE19533975A1 (de) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl-diazinone |
PT971901E (pt) * | 1997-01-15 | 2003-07-31 | Altana Pharma Ag | Ftalazinonas |
JP2001513097A (ja) | 1997-02-28 | 2001-08-28 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | Pde−抑制物質とアデニル酸シクラーゼ・アゴニストもしくはグアニル酸シクラーゼ・アゴニストとからなる相乗的組み合わせ組成物 |
US6380196B1 (en) | 1997-12-15 | 2002-04-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dihydrobenzofurans |
AU1760399A (en) * | 1997-12-15 | 1999-07-05 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New phthalazinones |
EP0934933A1 (en) | 1998-02-06 | 1999-08-11 | Byk Gulden Lomberg Chemische Fabrik GmbH | Phthalazinones |
MY126544A (en) | 1998-08-26 | 2006-10-31 | Smithkline Beecham Corp | Therapies for treating pulmonary diseases |
-
2001
- 2001-06-01 WO PCT/EP2001/006230 patent/WO2001094319A1/en active IP Right Grant
- 2001-06-01 HU HU0301240A patent/HUP0301240A3/hu unknown
- 2001-06-01 IL IL15284601A patent/IL152846A0/xx unknown
- 2001-06-01 SK SK1705-2002A patent/SK17052002A3/sk not_active Application Discontinuation
- 2001-06-01 US US10/296,411 patent/US6933296B2/en not_active Expired - Fee Related
- 2001-06-01 NZ NZ522882A patent/NZ522882A/en unknown
- 2001-06-01 EP EP01936419A patent/EP1296956A1/en not_active Withdrawn
- 2001-06-01 CA CA002411351A patent/CA2411351A1/en not_active Abandoned
- 2001-06-01 KR KR1020027016611A patent/KR20030031907A/ko not_active Application Discontinuation
- 2001-06-01 MX MXPA02012042A patent/MXPA02012042A/es unknown
- 2001-06-01 BR BR0111440-9A patent/BR0111440A/pt not_active IP Right Cessation
- 2001-06-01 CZ CZ20023997A patent/CZ20023997A3/cs unknown
- 2001-06-01 JP JP2002501869A patent/JP2003535850A/ja active Pending
- 2001-06-01 EA EA200201252A patent/EA005824B1/ru not_active IP Right Cessation
- 2001-06-01 AU AU2001262332A patent/AU2001262332B2/en not_active Ceased
- 2001-06-01 CN CNA018106870A patent/CN1471515A/zh active Pending
- 2001-06-01 PL PL01358057A patent/PL358057A1/xx not_active Application Discontinuation
- 2001-06-01 AU AU6233201A patent/AU6233201A/xx active Pending
-
2002
- 2002-11-26 ZA ZA200209598A patent/ZA200209598B/en unknown
- 2002-12-03 NO NO20025811A patent/NO20025811L/no not_active Application Discontinuation
-
2003
- 2003-06-24 HK HK03104534.2A patent/HK1052346A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU6233201A (en) | 2001-12-17 |
MXPA02012042A (es) | 2004-08-19 |
AU2001262332B2 (en) | 2006-05-25 |
CN1471515A (zh) | 2004-01-28 |
JP2003535850A (ja) | 2003-12-02 |
EA005824B1 (ru) | 2005-06-30 |
HUP0301240A3 (en) | 2004-03-29 |
HUP0301240A2 (hu) | 2003-12-29 |
WO2001094319A1 (en) | 2001-12-13 |
CA2411351A1 (en) | 2001-12-13 |
NO20025811D0 (no) | 2002-12-03 |
EP1296956A1 (en) | 2003-04-02 |
KR20030031907A (ko) | 2003-04-23 |
NO20025811L (no) | 2003-02-04 |
PL358057A1 (en) | 2004-08-09 |
SK17052002A3 (sk) | 2003-12-02 |
US6933296B2 (en) | 2005-08-23 |
CZ20023997A3 (cs) | 2003-05-14 |
ZA200209598B (en) | 2003-07-29 |
HK1052346A1 (zh) | 2003-09-11 |
US20030195215A1 (en) | 2003-10-16 |
IL152846A0 (en) | 2003-06-24 |
EA200201252A1 (ru) | 2003-06-26 |
NZ522882A (en) | 2004-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0111440A (pt) | Compostos eficazes como agonistas do (beta)2-adrenorreceptor bem como inibidores de pde4 | |
BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
BR0208192A (pt) | Derivados espirotricìclicos e seu uso como inibidores da fosfodiesterase-7. | |
BR9913745A (pt) | Cetonas de piridina úteis como herbicidas | |
BR9811730A (pt) | Derivados de n-aroilfenilalanina | |
BR0109188A (pt) | Diarilaminas 5-amida substituìdas como inibidores de mex | |
BR9908757A (pt) | Derivados de 3-hidróxi-4-aril-5-oxopirazolina herbicidamente ativos | |
BRPI0606379A2 (pt) | triazolftalazinas | |
BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
BR9811988A (pt) | Derivados de n-alcanoilfenilalanina | |
YU64701A (sh) | Jedinjenja upotrebljiva kao anti-inflamatorna sredstva | |
BR0308967A (pt) | Derivados de quinolina e isoquinolina, um processo para a sua preparação e sua aplicação como inibidores de inflamação | |
BR0111981A (pt) | herbicidas de piridina substituìda | |
DK1017692T3 (da) | 4-Heteroaryl-tetrahydroquinoliner og deres anvendelse som inhibitorer af cholesterolester-transferproteiner | |
BR0200782A (pt) | Compostos para o tratamento da isquemia | |
BR0309556A (pt) | Inibidores de metaloproteinase pirimidina-2,4,6-triona | |
BR0109317A (pt) | Composições contendo componentes agonistas alfa-2-adrenérgicos | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BRPI0412130A (pt) | compostos tetracìclicos como inibidores de c-met | |
UY25712A1 (es) | Benzamidas sustituidas y su aplicación en medicamentos | |
BRPI0411092A (pt) | benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos | |
BRPI0511323A (pt) | tetraidroisoquinolinas substituìdas usadas na forma de inibidores de mmp, método para a produção e uso das mesmas na forma de drágeas | |
ATE476419T1 (de) | Isochinolinon-kaliumkanalinhibitoren | |
YU60101A (sh) | Derivati rezorcinola | |
EA200100517A1 (ru) | Антагонисты 5ht1 для антидепрессантной терапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009. |